Boyd Peter E.
Chief People Officer
Boyd Peter E. has filed 6 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: May 7, 2026.
On the most recent filing, Boyd Peter E. is listed as Chief People Officer at Aquestive Therapeutics, Inc. Inside the rolling window, Boyd Peter E. reported no open-market purchases and 1 open-market sale totaling $124K in AQST.
Companies traded
Other insiders at AQST
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$124K
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
Frequently asked questions
How many SEC Form 4 filings has Boyd Peter E. made?
Boyd Peter E. has filed 6 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.
Which companies does Boyd Peter E. trade?
Boyd Peter E. has filed SEC Form 4 disclosures for 1 company, including AQST.
When was Boyd Peter E.'s most recent SEC Form 4 filing?
Boyd Peter E.'s most recent SEC Form 4 filing on Tracefour is dated May 7, 2026.
What is Boyd Peter E.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Boyd Peter E. is listed as Chief People Officer.
What is Boyd Peter E.'s total buy and sell value in the current window?
Inside the rolling retention window, Boyd Peter E. bought $0 and sold $124K based on SEC Form 4 filings.
What was Boyd Peter E.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 29,814 AQST shares on 2026-03-10, worth $124K, per SEC Form 4 filings.